These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4066083)

  • 1. Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue.
    Braga PC; Scaglione F; Scarpazza G; Fraticelli G; Roviaro G; Varoli F; Mariani C; Falchi M; Fraschini F
    Int J Clin Pharmacol Res; 1985; 5(5):331-40. PubMed ID: 4066083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of S-carboxymethylcysteine on blood levels of amoxycillin and its diffusion through lung parenchyma and pleural exudate in the rat].
    Broccali G; Peviani N; Nusdeo O; Dorigotti L
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):58-63. PubMed ID: 7126330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum and bronchial concentrations of amoxicillin administered with a bronchial fluidizer].
    Concia E; Dos Santos C; Marone P; Sardi C; Cremaschi P
    Boll Ist Sieroter Milan; 1982 Mar; 61(1):64-70. PubMed ID: 7126331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of seaprose on erythromycin penetration into bronchial mucus in bronchopulmonary infections.
    Braga PC; Piatti G; Grasselli G; Casali W; Beghi G; Allegra L
    Drugs Exp Clin Res; 1992; 18(3):105-11. PubMed ID: 1425205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacampicillin, amoxycillin and talampicillin concentrations in bronchial secretions.
    Schönwald S; Beus I; Car V; Mahovlić V; Jeren T; Plavsić F; Brlić V
    Int J Clin Pharmacol Res; 1988; 8(4):263-6. PubMed ID: 3182115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of ampicillin ('Pondocillin') and amoxycillin ('Imacillin') into bronchial secretions.
    Hagstad H
    Pharmatherapeutica; 1984; 3(10):692-7. PubMed ID: 6463069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
    Silvia G; Giambrone F; Battaglia E; Romano M
    G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
    [No Abstract]   [Full Text] [Related]  

  • 8. Brodimoprim concentrations in bronchial mucosa, bronchial secretions and middle ear effusions.
    Scaglione F; Cogo R; Pintucci JP; Demartini G; Dugnani S; Maccarinelli G; Fraschini F
    J Chemother; 1993 Dec; 5(6):490-3. PubMed ID: 8195843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
    Peralta J; Poderoso JJ; Corazza C; Fernández M; Guerreiro RB; Wiemeyer JC
    Arzneimittelforschung; 1987 Aug; 37(8):969-71. PubMed ID: 3675696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis.
    Braga PC; Borsa M; De Angelis L; Bossi R; Allegra L; Scaglione F; Scarpazza G
    Clin Ther; 1982; 4(6):480-8. PubMed ID: 7093981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of beta-lactam antibiotics in bronchial secretions.
    Bergogne-Berezin E; Morel C; Benard Y; Berthelot G; Kafe H
    Scand J Infect Dis Suppl; 1978; (14):267-72. PubMed ID: 279981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbocysteine-sobrerol combination and exacerbation of chronic bronchitis].
    Pasturenzi L; Donnetta AM; Gualtieri G; Luisetti M
    Arch Monaldi Mal Torace; 1988; 43(6):487-505. PubMed ID: 3155012
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
    Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
    Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in sputum in catarrhal bronchitis in children after treatment with S-carboxymethylcysteine (viscosimetric studies)].
    Castello D; Costa G; De Candussio G
    Minerva Pediatr; 1979 Mar; 31(5):371-80. PubMed ID: 460097
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of a fluidifying agent (bromhexine) on the penetration of antibiotics into respiratory secretions.
    Bergogne-Bérézin E; Berthelot G; Kafé HP; Dournovo P
    Int J Clin Pharmacol Res; 1985; 5(5):341-4. PubMed ID: 4066084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fleroxacin versus amoxicillin in the treatment of acute exacerbation of chronic bronchitis.
    Ulmer W
    Am J Med; 1993 Mar; 94(3A):136S-141S. PubMed ID: 8452170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of subpopulations of bronchitic patients for suitable therapy by a dynamic rheological test.
    Braga PC; Allegra L; Bossi R; Guffanti EE; Scarpazza G; Bisetti A; Spada E; Fumagalli G
    Int J Clin Pharmacol Res; 1989; 9(3):175-82. PubMed ID: 2744910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Optimal use of expectorants (current trends)].
    Mirrakhimov MM; Brimkulov NN; Rafibekova ZhS
    Ter Arkh; 1981; 53(1):110-7. PubMed ID: 7013137
    [No Abstract]   [Full Text] [Related]  

  • 19. No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
    Thomson ML; Pavia D; Jones CJ; McQuiston TA
    Thorax; 1975 Dec; 30(6):669-73. PubMed ID: 769242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of the clinical effectiveness of the mucolytic drug, S-carboxymethylcysteine, in the therapy of acute and chronic bronchitis].
    Magliulo E; Bonizzoni D; Cattaneo E; Scevola D; Concia E
    Minerva Med; 1975 Apr; 66(25):1187-97. PubMed ID: 1134660
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.